MedTrace Logo

Metoclopramide for Migraine: A Dose Finding Study

NCT00682734 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2018-05-31

Study results available
· View outcomes & findings →

Summary

Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.

Conditions

Interventions

DRUG

metoclopramide

metoclopramide 20 mg

DRUG

metoclopramide

metoclopramide 40 mg

DRUG

metoclopramide

metoclopramide 10 mg

DRUG

Diphenhydramine 25mg

Diphenhydramine 25mg, administered as an intravenous drip over 20 minutes

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Benjamin W. Friedman, MD, MS · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00682734 on ClinicalTrials.gov